Project Grant R15AG101712
Award Date 6/1/26
Completion Date 5/31/29
Dollars Obligated $624K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Charlestown, MA 02129, USA
Similar Awards
- Federal Grant Award Summary Boston University Medical Campus received a $327,000 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866), awarded September 5, 2025, with completion scheduled for August 31, 2027. The grant supports research exploring heterogeneity of cognitive trajectories in preclinical Alzheimer's disease through digital phenotyping methodologies. The project leverages multimodal data integration, combining traditional...
- Federal Grant Award Summary Brigham & Women's Hospital received a $3.69 million Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) awarded on September 15, 2025, with a completion date of September 14, 2029. The award funds development of specialized large language models (LLMs) designed to extract Alzheimer's disease and related dementias (ADRD)-relevant clinical phenotypes from electronic health records (EHRs). The project addresses a critical...
- Federal Project Grant Award Summary The National Institute on Aging awarded a $470,000 Project Grant under the Aging Research program (CFDA 93.866) to Tufts University School of Medicine, with performance in Boston, Massachusetts. The award, effective February 1, 2026 through January 31, 2028, funds research to elucidate the interplay between Alzheimer's disease (AD) genetic variants using human induced pluripotent stem cell (iPSC)-derived brain cells. This two-year project addresses the genetic...
- Federal Project Grant Award Summary The University of Massachusetts Medical School received a $445,130 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) beginning January 1, 2026 and concluding December 31, 2030. This award funds biomedical research directed toward elucidating the mechanisms by which MS4A (Membrane Spanning 4A) genes regulate neurodegeneration in Alzheimer's disease and related disorders, including frontotemporal dementia, multiple...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded J. David Gladstone Institutes a Project Grant of $1,459,072 on August 1, 2025, under the Aging Research program (CFDA 93.866) to conduct research on Alzheimer's Disease (AD)-related neurological dysfunction. The research will deliver scientific knowledge and methodological innovations focused on understanding how inhibitory interneurons—specifically parvalbumin (PVALB) and somatostatin (SST) cell types—contribute...
- Federal Project Grant Award Summary Massachusetts General Hospital received a $1.34M Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) awarded April 15, 2026, with completion targeted for March 31, 2031. The award supports research to develop advanced high-resolution magnetic resonance imaging (MRI) methodologies for noninvasively tracking cerebrospinal fluid (CSF) flow dynamics and amyloid-beta (AB) diffusion through perivascular spaces (PVS) in...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded $2,557,950 to The Feinstein Institutes for Medical Research under the Aging Research program (CFDA 93.866) on May 15, 2026, for research investigating the role of neurotoxic astrocytes in Alzheimer's disease (AD) pathogenesis. This R01 Project Grant, which extends through April 30, 2030, focuses on elucidating a novel molecular mechanism whereby extracellular cold-inducible RNA-binding protein (ECIRP) induces...
- Grant Award Summary The National Institute on Aging, under the Aging Research program (CFDA 93.866), awarded $4.59 million to the Regents of the University of California, San Francisco for a four-year project (September 5, 2025 through August 31, 2029) to develop and validate automated speech analysis technology for early detection of Alzheimer's disease (AD). The primary deliverable is an AD-specific speech profile utilizing machine learning algorithms to identify linguistic and acoustic...
- Federal Project Grant Summary The National Institute on Aging awarded $458,622 to the Research Foundation For Mental Hygiene, Inc. (operating as the New York State Psychiatric Institute) under the Aging Research program (CFDA 93.866) on March 1, 2026, with completion targeted for February 29, 2028. This project grant supports innovative research to elucidate the neuronal mechanisms and therapeutic potential of focused ultrasound-induced blood-brain barrier opening (FUS-BBBO) as a novel treatment...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded Boston Children's Hospital a Project Grant totaling $335,880 under the Aging Research program (CFDA 93.866) on August 15, 2025, with a completion date of May 31, 2030. This grant supports research aimed at elucidating the neuronal mechanisms underlying cognitive resilience to Alzheimer's disease (AD). The project addresses a critical gap in AD treatment by investigating why approximately 10-15% of individuals maintain...